Crossmark

Investigating the feasibility of stratified breast cancer screening using a masking risk predictor

Published Online: 2019-08-09

Published Print: 2019-12

Authors

Alonzo-Proulx, Olivier

Mainprize, James G.

Harvey, Jennifer A.

Yaffe, Martin J.
Funding

Funding for this research was provided by:

Ontario Institute for Cancer Research (Adaptive Oncology)
License Information

Text and Data Mining valid from 2019-08-09

Version of Record valid from 2019-08-09
More Information

Article History

Received: 25 March 2019

Accepted: 26 July 2019

First Online: 9 August 2019

Ethics approval and consent to participate

: This study had institutional review board approval. All patients underwent informed consent for participation in the original study. The need for additional consent for this study was waived, as only existing de-identified data were used in this analysis. The study was compliant with the Health Insurance Portability and Accountability Act. The committee’s reference number is IRB-HSR #15885.

: Not applicable.

: JAH has the following conflict: shareholder and research agreement with Volpara Analytics, LLC, Wellington, NZ. MJY has the following conflict: shareholder of Volpara Analytics, LLC, Wellington, NZ. The other authors declare that they have no competing interests.

Document is current